Metformin is shown to decrease gluconeogenesis, improve insulin resistance, decrease circulating insulin levels, and exert an inhibitory effect on the proliferation, and invasiveness of EC cells in preclinical studies [42,43,44,45,46]. Here, INS is linked to Insulin resistance.